Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Director departure
Letter to company
Asset disposition
Appointed director
|
|
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/28/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/26/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 03/18/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 03/15/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 03/15/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 03/31/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 03/23/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 03/16/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 03/14/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 03/18/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 03/06/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
| 03/16/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
| 03/31/2010 |
10-K
| Annual Report for the period ended December 31, 2009 |
| 03/30/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
| 03/31/2008 |
10-K
| Annual Report for the period ended December 31, 2007 |
| 03/31/1999 |
10-K
| Annual Report for the period ended December 31, 1998 |
| 03/31/1998 |
10-K
| Annual Report for the period ended December 31, 1997 |
|
|